| (1) | * Estimated solely for purposes of calculating the
filing fee. The transaction valuation was calculated by adding (a) the product
of (i) $77.00 (the “Offer Price”)
and (ii) 21,229,087 Shares issued and outstanding, (b) the product of (i) 3,808,204
Shares pursuant to outstanding options granted and outstanding under equity
plans with an exercise price less than the Offer Price and (ii) the excess of
the Offer Price over $13.97 (the weighted average exercise price of such
options as of July 24, 2026), (c) the product of (i) 590,608 restricted stock units
and (ii) the Offer Price, (d) the product of (i) 3,474 Shares subject to
outstanding purchase rights under the Company ESPP and (ii) the excess of the
Offer Price over $21.32 (the purchase price for the Shares subject to
outstanding purchase rights under the Company ESPP), (e) the product of (i)
619,606 Shares subject to issuance pursuant to the 2025 Warrants issued and
outstanding and (ii) the excess of the Offer Price over $0.001 (the exercise
price for the 2025 Warrants), and (f) the product of (i) 2,598,089 Shares
subject to issuance pursuant to the 2024 Warrants issued and outstanding and
(ii) the excess of the Offer Price over $0.001 (the exercise price for the 2024
Warrants). Except as otherwise noted, the calculation of the filing fee is
based on information provided by Forte as of July 23, 2026. The filing fee was
calculated in accordance with Rule 0-11 under the Securities Exchange Act of
1934, as amended, and Fee Rate Advisory for Fiscal Year 2026, effective October
1, 2025, by multiplying the transaction value by 0.00013810. |